Tag Archives: Supreme Court

Fed. Cir. Orders Briefing in Myriad Remand

Posted on May 1, 2012 by Warren Woessner

On April 30th, in response to the Supreme Court’s GVR of the Myriad appeal (AMP et al. are still trying to get the claims to isolated DNA molecules and the use of a transgenic cell comprising the BRCA1 gene to … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , , | 1 Comment

Sherley v. Sibelius – The Undead Threat To Stem Cell Funding

Posted on April 26, 2012 by Warren Woessner

Green Energy Sources When a three judge panel of the US Court of Appeals for the D.C. Cir. dismissed a preliminary injunction obtained by plaintiffs in April 2011, and the lower court judge then  dismissed plaintiffs’ suit to block the … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , , , , , | Leave a comment

Supreme Court Reverses In Caraco Appeal

Posted on April 17, 2012 by Warren Woessner

Today, in Caraco Pharmaceutical Laboratories, Ltd. v. Novo Nordisk, in an opinion authored by Justice Kagan (a copy can be found at the end of this post), the Court reversed the Fed. Cir.’s divided 2010 decision that an ANDA filer … Continue reading →

Posted in Hatch-Waxman | Tagged , , , , , , , , , , , , , , | 1 Comment

Prometheus Q/A – Which Side Are You On?

Posted on April 12, 2012 by Warren Woessner

A guest post from Robin Chadwick of SLW. During the three weeks since the Supreme Court ruled that certain diagnostic claims are not eligible for patenting, four other patent cases have been impacted by this ruling. The Court is shaping … Continue reading →

Posted in Patent Eligible Subject Matter | Tagged , , , , | 1 Comment